Cardiac transplantation for hypertrophic cardiomyopathy: A valid therapeutic option

Journal of Heart and Lung Transplantation

Volumn 23, Issue 4, 2004, Pages 413-417

  Coutu, Marianne ^a   Perrault, Louis P ^a   White, Michel ^a   Pelletier, Guy B ^a   Racine, Normand ^a   Poirier, Nancy C ^a,b   Carrier, Michel ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; AZATHIOPRINE; CYCLOSPORIN A; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DYSTROPHIN; HEPARIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; WARFARIN;

ANTICOAGULATION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRADYCARDIA; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DNA DETERMINATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EMERY DREIFUSS MUSCULAR DYSTROPHY; GRAFT REJECTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL EXAMINATION; MONOZYGOTIC TWINS; MOTOR DEVELOPMENT; MUSCLE BIOPSY; MUSCLE CONTRACTURE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; NEUROMUSCULAR DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; SCHOOL CHILD; STROKE; SUPRAVENTRICULAR TACHYCARDIA; SYMPTOM; TREATMENT OUTCOME; ADOLESCENT; ADULT; CHILD; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FOLLOW UP; HYPERTROPHIC CARDIOMYOPATHY; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL;

ACTUARIAL ANALYSIS; ADOLESCENT; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1842529439     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(03)00204-3     Document Type: Article

References (17)

1. Maron B.J. Hypertrophic cardiomyopathy. Curr Probl Cardiol. 18:1993;639-704.
2. Ferraro P., Carrier M., White M., Pelletier G.B., Pelletier L.C. Antithymocyte globulin and methotrexate therapy of severe or persistent cardiac allograft rejection. Ann Thorac Surg. 60:1995;372-376.
3. Ross H, Hendry P, Dipchand A, et al. Transplant coronary artery disease. In: Cardiac Transplantation. Canadian Cardiovascular Society Consensus Conference, Can J Cardiol 2003;19:620-54.
4. Lower R.R., Shumway N.E. Studies of orthotopic cardiac homotransplantations of the canine heart. Surg Forum. 11:1960;18-19.
5. Codd M.B., Suegrue D.D., Gersh B.J., Melton L.J. III. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted Country, 1975-1984. Circulation. 80:1989;564-572.
6. Davies M.J., Krikler D.M. Genetic investigation and counseling of families with hypertrophic cardiomyopathy. Br Heart J. 72:1994;99-101.
7. Clark A.L., Coats A.J. Screening for hypertrophic cardiomyopathy. Br Med J. 306:1993;409-410.
8. Spirito P., Chiarella F., Carratino L., Berisso M.Z., Bellotti P., Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 320:1989;749-755.
9. Shirani J., Maron B.J., Cannon R.O., et al. Clinicopathological features of hypertrophic cardiomyopathy managed by cardiac transplantation. Am J Cardiol. 73:1993;434-440.
10. Vassali G., Seiler C., Hess O.M. Risk stratification in hypertrophic cardiomyopathy. Curr Opin Cardiol. 9:1994;330-336.
11. Maron B.J., Kogan J., Proschan M.A., Hecht G.M., Robertsd W.C. Circadian variability in the occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 23:1994;1405-1409.
12. DeRose J.J., Banas J.S., Winters S.L. Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 36:1994;475-484.
13. McAreavey D., Fananapazir L. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol. 70:1992;651-656.
14. Knight C., Kurbaan A.S., Seggewiss H., et al. Nonsurgical septal reduction for obtructive cardiomyopathy outcome of the first series of patients. Circulation. 95:1997;2075-2081.
15. Seggewiss H., Faber L., Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg. 47:1999;94-100.
16. Delahaye F., Jegadan O., Gevigney G., et al. Postoperative and long-term prognosis of myotomy-myomectomy for obstructive hypertrophic cardiomyopathy influence of associated mitral valve replacement. Eur Heart J. 14:1993;1229-1237.
17. Brown P.S., Roberts C.S., McIntosh C.L., et al. Aortic regurgitation after left ventricular myotomy and myectomy. Ann Thorac Surg. 51:1991;585-592.